AAAAAA

   
Results: 1-12 |
Results: 12
REGULATION OF ERYTHROPOIESIS BY BONE-MARROW RENINANGIOTENSIN SYSTEM -FACTS AND SPECULATIONS
Authors: PRALORAN V COMTE L LEMEUR Y ALDIGIER JC
Citation: V. Praloran et al., REGULATION OF ERYTHROPOIESIS BY BONE-MARROW RENINANGIOTENSIN SYSTEM -FACTS AND SPECULATIONS, Experimental hematology, 26(11), 1998, pp. 1020-1021
IN-VIVO MODIFICATIONS OF ACSDKP METABOLISM AND HEMATOPOIESIS IN MICE TREATED WITH 5-FLUOROURACIL AND GORALATIDE
Authors: COMTE L LORGEOT V BIGNON J VOLKOV L DUPUIS F WDZIECZAKBAKALA J PRALORAN V
Citation: L. Comte et al., IN-VIVO MODIFICATIONS OF ACSDKP METABOLISM AND HEMATOPOIESIS IN MICE TREATED WITH 5-FLUOROURACIL AND GORALATIDE, European journal of clinical investigation, 28(10), 1998, pp. 856-863
VARIATIONS OF CELLULAR ACSDKP CONCENTRATIONS DURING THE GROWTH PHASESOF MS-K AND NJE CONTINUOUS CELL-LINES
Authors: VOLKOV L COMTE L LACROIX P PRALORAN V
Citation: L. Volkov et al., VARIATIONS OF CELLULAR ACSDKP CONCENTRATIONS DURING THE GROWTH PHASESOF MS-K AND NJE CONTINUOUS CELL-LINES, The Cancer journal, 10(6), 1997, pp. 339-340
ACSDKP PLASMA-CONCENTRATIONS IN PATIENTS WITH SOLID TUMORS - COMPARISON OF 2 CHEMOTHERAPEUTIC REGIMENS
Authors: COMTE L LORGEOT V VOLKOV L ROULLET B TUBIANA N PRALORAN V
Citation: L. Comte et al., ACSDKP PLASMA-CONCENTRATIONS IN PATIENTS WITH SOLID TUMORS - COMPARISON OF 2 CHEMOTHERAPEUTIC REGIMENS, Cancer letters, 112(1), 1997, pp. 1-4
PRODUCTION AND CONSUMPTION OF THE TETRAPEPTIDE ACSDKP, A NEGATIVE REGULATOR OF HEMATOPOIETIC STEM-CELLS, BY HEMATOPOIETIC MICROENVIRONMENTAL CELLS
Authors: LI J VOLKOV L COMTE L HERVE P PRALORAN V CHARBORD P
Citation: J. Li et al., PRODUCTION AND CONSUMPTION OF THE TETRAPEPTIDE ACSDKP, A NEGATIVE REGULATOR OF HEMATOPOIETIC STEM-CELLS, BY HEMATOPOIETIC MICROENVIRONMENTAL CELLS, Experimental hematology, 25(2), 1997, pp. 140-146
EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL ON BLOOD HEMATOPOIETIC PROGENITORS AND ACETYL-N-SER-ASP-LYS-PRO CONCENTRATIONS
Authors: COMTE L LORGEOT V VOLKOV L ALLEGRAUD A ALDIGIER JC PRALORAN V
Citation: L. Comte et al., EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL ON BLOOD HEMATOPOIETIC PROGENITORS AND ACETYL-N-SER-ASP-LYS-PRO CONCENTRATIONS, European journal of clinical investigation, 27(9), 1997, pp. 788-790
THE TETRAPEPTIDE ACSDKP, A PHYSIOLOGICAL INHIBITOR OF NORMAL-CELL PROLIFERATION, REDUCES THE S-PHASE ENTRY OF CONTINUOUS CELL-LINES
Authors: VOLKOV L QUERE P COUDERT F COMTE L PRALORAN V
Citation: L. Volkov et al., THE TETRAPEPTIDE ACSDKP, A PHYSIOLOGICAL INHIBITOR OF NORMAL-CELL PROLIFERATION, REDUCES THE S-PHASE ENTRY OF CONTINUOUS CELL-LINES, Experimental cell research, 223(1), 1996, pp. 112-116
THE TETRAPEPTIDE ACSDKP, A NEGATIVE REGULATOR OF CELL-CYCLE ENTRY, INHIBITS THE PROLIFERATION OF HUMAN AND CHICKEN LYMPHOCYTES
Authors: VOLKOV L QUERE P COUDERT F COMTE L ANTIPOV Y PRALORAN V
Citation: L. Volkov et al., THE TETRAPEPTIDE ACSDKP, A NEGATIVE REGULATOR OF CELL-CYCLE ENTRY, INHIBITS THE PROLIFERATION OF HUMAN AND CHICKEN LYMPHOCYTES, Cellular immunology, 168(2), 1996, pp. 302-306
PAF AND HEMATOPOIESIS .4. MODIFICATIONS OF SPLEEN AND THYMUS PAF CONTENTS AFTER A SINGLE-DOSE OF THE CHEMOTHERAPEUTIC DRUG 5-FLUOROURACIL IN MICE
Authors: DENIZOT Y DUPUIS F COMTE L DULERY C PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .4. MODIFICATIONS OF SPLEEN AND THYMUS PAF CONTENTS AFTER A SINGLE-DOSE OF THE CHEMOTHERAPEUTIC DRUG 5-FLUOROURACIL IN MICE, Cancer letters, 88(2), 1995, pp. 185-189
THE CONCENTRATIONS OF ACSDKP, A PHYSIOLOGICAL INHIBITOR OF CELL-PROLIFERATION, VARY DURING OOGENESIS AND EARLY DEVELOPMENT IN XENOPUS-LAEVIS
Authors: VOLKOV L COMTE L FRINDEL E PHILIPPE M PRALORAN V
Citation: L. Volkov et al., THE CONCENTRATIONS OF ACSDKP, A PHYSIOLOGICAL INHIBITOR OF CELL-PROLIFERATION, VARY DURING OOGENESIS AND EARLY DEVELOPMENT IN XENOPUS-LAEVIS, Biology of the cell, 85(2-3), 1995, pp. 223-225
ACSDKP SERUM CONCENTRATIONS VARY DURING CHEMOTHERAPY IN PATIENTS WITHACUTE MYELOID-LEUKEMIA
Authors: LIOZON E VOLKOV L COMTE L TRIMOREAU F PRADELLES P BORDESSOULE D FRINDEL E PRALORAN V
Citation: E. Liozon et al., ACSDKP SERUM CONCENTRATIONS VARY DURING CHEMOTHERAPY IN PATIENTS WITHACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 89(4), 1995, pp. 917-920
VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: LIOZON E VOLKOV L COMTE L TRIMOREAU F PRADELLES P BORDESSOULE D FRINDEL E PRALORAN V
Citation: E. Liozon et al., VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000305-10000305
Risultati: 1-12 |